These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2601584)

  • 1. The effect of debrisoquin on MAO A and MAO B activities.
    Javors MA; Bembenek ME; Bowden CL; Abell CW; Maas JW
    Life Sci; 1989; 45(24):2359-64. PubMed ID: 2601584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidases A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines.
    Bembenek ME; Abell CW; Chrisey LA; Rozwadowska MD; Gessner W; Brossi A
    J Med Chem; 1990 Jan; 33(1):147-52. PubMed ID: 2296014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitory activities of heterocyclic chalcones.
    Minders C; Petzer JP; Petzer A; Lourens AC
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
    Lee SS; Lee JJ; Cheong MJ; Kim YH; Kim Y; Yun YP; Lee CK; Lee MK
    Biol Pharm Bull; 2001 Jul; 24(7):838-40. PubMed ID: 11456127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl 1-alanine and its analogs.
    DeFeudis FV
    Rev Clin Basic Pharm; 1988; 7(1-4):207-8. PubMed ID: 3247497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).
    Herraiz T; Brandt SD
    Drug Test Anal; 2014; 6(7-8):607-13. PubMed ID: 24115740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase by 3,4-dihydroxyphenyl L-alanine and its analogues.
    Naoi M; Nagatsu T
    Life Sci; 1987 Jan; 40(4):321-8. PubMed ID: 3100896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase by 7-chloro-4-nitrobenzofurazan.
    Fu RC; Liu XF; Chen SU
    J Neurochem; 1990 Sep; 55(3):813-8. PubMed ID: 2384754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference.
    Dorris RL
    J Pharmacol Methods; 1982 Mar; 7(2):133-7. PubMed ID: 7098495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase (MAO) by α-ethylphenethylamine and N,α-diethylphenethylamine, two compounds related to dietary supplements.
    Santillo MF
    Food Chem Toxicol; 2014 Dec; 74():265-9. PubMed ID: 25455893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of monoamine oxidase by esomeprazole.
    Petzer A; Pienaar A; Petzer JP
    Drug Res (Stuttg); 2013 Sep; 63(9):462-7. PubMed ID: 23677700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.